On paper, biosimilars have great potential to cut development costs, expand patient access to biologics, and improve affordability. The practical reality is that these goals are difficult to achieve.

In the United States, where around 8 million people rely on insulin for diabetes management, soaring prices have created barriers to accessibility. As Congress takes initial steps to cap monthly ...

Pharmacy benefit managers received substantial attention during 2024. Congress and regulating agencies including the FTC and HHS scrutinized PBM business practices and related profits. As a new ...

Samsung Biologics has had a busy year, tying up separate production pacts with the likes of Pfizer, Eli Lilly and GSK. (Veradigm) After inking and expanding a biosimilar production partnership with ...

Biosimilars trade groups and manufacturers have expressed concern about what they say are “unnecessary hurdles” present in the US Food and Drug Administration’s (FDA) recent draft guidance on ...

A biosimilar drug manufacturer is concentrating on process optimization to increase uptake of its products in lower-income countries. According to Jeffrey Hausfeld, MD, chairman of the board of ...

Sandoz expects construction on the biologics plant to start this year and that the facility will be ready to run by late 2026. (Photo by Martin Schutt/picture alliance via Getty Images) Novartis may ...

Presenters explored the real-world evidence in support of biosimilars at the Academy of Managed Care Pharmacy 2024 annual meeting. Biosimilars were a recurring subject at the Academy of Managed Care ...

Providers and patients who want to understand biosimilars can now navigate through a new web app, that was created by Prime, and delivered in partnership with the AMCP Foundation and Biosimilars ...

Solna, Sweden and Richmond, CA, US - Xbrane Biopharma AB ("Xbrane"), a Sweden-based biotechnology company focused on the development of biosimilars, and JOINN Biologics US Inc. ("JOINN"), a US-based l ...

Fill out the form below, and we shall send your colleague an invitation to the "Media Design Strategies for High-Quality Biosimilars: Productivity and Glycosylation Control" event. Mammalian cell ...